Conference Reports

Chicago, Illinois, US
02 June 2017 - 06 June 2017
Geneva
05 May 2017 - 08 May 2017
Orlando, Florida
16 February 2017 - 18 February 2017
Amsterdam
27 January 2017 - 30 January 2017
Singapore
16 December 2016 - 19 December 2016
San Diego, California
03 December 2016 - 06 December 2016
San Antonio, Texas
06 December 2016 - 10 December 2016
Vienna
04 December 2016 - 07 December 2016
Copenhagen
07 October 2016 - 11 October 2016
Singapore
20 July 2016 - 24 July 2016
Chiang Mai
13 May 2016 - 15 May 2016
Geneva
13 April 2016 - 16 April 2016
San Francisco, CA
07 January 2016 - 09 January 2016
San Antonio, Texas, US
08 December 2015 - 12 December 2015
Orlando, Florida, US
05 December 2015 - 08 December 2015
San Antonio, TX
18 October 2015 - 21 October 2015
Vienna
25 September 2015 - 29 September 2015
Philadelphia, PA
18 April 2015 - 22 April 2015
Geneva
15 April 2015 - 18 April 2015
San Antonio, TX
09 December 2014 - 13 December 2014
San Francisco, CA
06 December 2014 - 09 December 2014
21 November 2014 - 22 November 2014
Chicago, Illinois
30 May 2014 - 03 June 2014
Tel Aviv
18 June 2014 - 19 June 2014
Geneva
26 March 2014 - 29 March 2014
San Antonio
10 December 2013 - 14 December 2013
New Orleans, Louisiana
07 December 2013 - 10 December 2013
Amsterdam
27 September 2013 - 01 October 2013
Chicago, Illinois
31 May 2013 - 04 June 2013
Washington D.C
06 April 2013 - 10 April 2013
08 November 2012 - 09 November 2012
San Antonio Texas
04 December 2012 - 08 December 2012
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Naomi Adam, 2 years ago
Colorectal cancer is one of the leading cancers worldwide and one of the most difficult to treat because patients often present in later, metastatic stages of disease. Preventing blood vessel growth is a popular therapeutic strategy to help reduce the proliferation of cancerous tissue. Aflibercept (Zaltrap®, Sanofi) is a monoclonal antibody treatment that targets the cell signalling pathways of angiogenesis to prevent blood vessel growth in malignancies.
one year ago
A phase III, randomized, multi-center trial showed that dexamethasone helped reduce the incidence of radiation-induced pain flare in the treatment of bone metastases.
one year ago
Patients with advanced, epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) obtain survival benefit from EGFR tyrosine kinase inhibitor (TKI) treatment, a meta-analysis has shown.
Radha Chitale, one year ago
Genetically engineered T cells that target and destroy plasma cells may have the potential to cure patients with advanced multiple myeloma (MM), according to the results of a small, phase I/II trial in which one patient with over 90 percent of bone marrow cells affected was cleared of myeloma 1 month after treatment and researchers say he remains in stringent complete remission. [ASH 2015, abstract LBA 1]